A flurry of IPOs joined the calendar to kick off the new year, most notably ADT. Less than two years since Apollo took the security services behemoth private, ADT (ADT) launched a $2 billion public offering that will value the company at $14 billion.
After ...read more
Cue Biopharma, a preclinical biotech developing T cell immuno-oncology therapies, announced on Tuesday that it had closed its initial public offering in late December. The company raised $66 million. Its stock also began trading on the Nasdaq on Tuesday under...read more
Cue Biopharma, a preclinical biotech developing T cell immuno-oncology therapies, filed a 424B1 final prospectus with the SEC and set the price of its min-max, best efforts IPO at $7.50. That price was proposed in its previous filing, and was toward...read more
Four companies are targeting $247 million in the last active week of the 2017 IPO market. LexinFintech, a Chinese online microloan company, leads the pack with the largest deal of the week. Other IPOs include a life insurer and two small health care deals....read more
US IPO Weekly Recap: IPO calendar begins to fill up in the first week of 2018
A flurry of IPOs joined the calendar to kick off the new year, most notably ADT. Less than two years since Apollo took the security services behemoth private, ADT (ADT) launched a $2 billion public offering that will value the company at $14 billion. After ...read more
Cue Biopharma closes $66 million best-efforts IPO; up about 50% on first day of trading
Cue Biopharma, a preclinical biotech developing T cell immuno-oncology therapies, announced on Tuesday that it had closed its initial public offering in late December. The company raised $66 million. Its stock also began trading on the Nasdaq on Tuesday under...read more
Cue Biopharma sets best efforts IPO price near high end at $7.50; will trade after selling minimum shares
Cue Biopharma, a preclinical biotech developing T cell immuno-oncology therapies, filed a 424B1 final prospectus with the SEC and set the price of its min-max, best efforts IPO at $7.50. That price was proposed in its previous filing, and was toward...read more
US IPO Week Ahead: 4-IPO week to close out 2017
Four companies are targeting $247 million in the last active week of the 2017 IPO market. LexinFintech, a Chinese online microloan company, leads the pack with the largest deal of the week. Other IPOs include a life insurer and two small health care deals....read more